3D Systems Corporation (DDD)
3D Systems (DDD) Reports Q4 Loss, Tops Revenue Estimates
3D Systems (DDD) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.19 per share a year ago.
3D Systems: Cash Flow Breakeven Could Unlock Multiple Expansion
3D Systems (DDD) is rated Buy with a $2.9 price target, offering 17% upside. Recent cost-saving initiatives target $50 million in annualized savings by year-end, aiming for OCF breakeven by 2026, driving potential re-rating. DDD's A&D segment grew 50% YoY, positioning the company to benefit from government-driven demand and sector tailwinds.
3D Systems' A&D Business Benefits From US Policy, Rising Investment
DDD's A&D business is set to grow more than 20% in 2026, fueled by U.S. policy shifts, defense demand and tech investments.
3D Systems' Posts Narrower Loss in Q3 Earnings, Revenues Down Y/Y
DDD posts a narrower Q3 loss despite a 19% revenue decline, with upbeat Q4 guidance hinting at stronger printer and healthcare demand ahead.
3D Systems Corporation (DDD) Q3 2025 Earnings Call Transcript
3D Systems Corporation ( DDD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Jeffrey Graves - President, CEO & Director Phyllis Nordstrom - Interim Chief Financial Officer & Chief Administrative Officer Conference Call Participants Troy Jensen Jackson Schroeder - Craig-Hallum Capital Group LLC, Research Division Alek Valero - Loop Capital Markets LLC, Research Division Presentation Operator Greetings, and welcome to the 3D Systems Third Quarter 2025 Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
3D Systems (DDD) Shows Fast-paced Momentum But Is Still a Bargain Stock
3D Systems (DDD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Is 3D Systems (DDD) Outperforming Other Industrial Products Stocks This Year?
Here is how 3D Systems (DDD) and Helios Technologies (HLIO) have performed compared to their sector so far this year.
Here Is Why Bargain Hunters Would Love Fast-paced Mover 3D Systems (DDD)
3D Systems (DDD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, 3D Systems (DDD) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, 3D Systems (DDD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
3D Systems Corporation (DDD) Q2 2025 Earnings Call Transcript
3D Systems Corporation (NYSE:DDD ) Q2 2025 Earnings Call August 12, 2025 8:30 AM ET Company Participants Jeffrey Alan Graves - President, CEO & Director Jeffrey D. Creech - Executive VP, Principal Accounting Officer & CFO Michael McCloskey - Treasurer & VP of Investor Relations Conference Call Participants Alek Oleg Valero - Loop Capital Markets LLC, Research Division Gregory William Palm - Craig-Hallum Capital Group LLC, Research Division James Andrew Ricchiuti - Needham & Company, LLC, Research Division Trevor R.
3D Systems (DDD) Reports Q2 Loss, Misses Revenue Estimates
3D Systems (DDD) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.14 per share a year ago.
3D Systems: Healthcare And Metal Pivot Drives Re-Rating
Initiate Strong Buy on 3D Systems with $4 PT, driven by healthcare and metal additive manufacturing pivots, despite near-term topline headwinds. Cost structure reset and Geomagic divestiture provide margin stabilization, liquidity, and operational flexibility, positioning DDD for a post-FY25 recovery. Healthcare and dental expansion, especially NextDent 300, are underappreciated catalysts for revenue growth and market re-rating into FY26.
